sanomics.ai

SanOmics (Hangzhou Shengao Information Technology Co., Ltd.) is an AI-powered medical innovation platform founded in 2021 and headquartered in Hangzhou, China. The company specializes in integrating artificial intelligence with multi-omics analysis to accelerate drug discovery and precision medicine. Its core offering is the MolProphet platform, a comprehensive, one-stop, general-purpose solution designed for the early stages of drug development. By utilizing proprietary deep learning algorithms and cloud computing, SanOmics provides tools for molecular design, virtual screening, and the generation of customized virtual compound libraries, aiming to improve novelty and synthetic feasibility while reducing research costs and timelines.

The platform serves hospitals, pharmaceutical companies, and research institutions by addressing critical bottlenecks in identifying new therapeutic targets and potential drug candidates. SanOmics supports its users through a range of professional CRO services, including the provision of specialized molecular libraries developed in collaboration with research partners. The efficacy of its AI-driven methodologies is supported by various academic publications in journals such as the Journal of Medicinal Chemistry and the Journal of Chemical Information and Modeling, where the company demonstrates the application of reinforcement learning and graph-based models in optimizing lead compounds and predicting molecular properties.